Patent details

Basic Information

Publication number:

EP3423489

PCT Application Number:

US2016039785

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP167367176

PCT Publication Number:

WO2017151176

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ANTIBODIES TO CD40 WITH ENHANCED AGONIST ACTIVITY

French Title of Invention:

ANTICORPS ANTI-CD40 PRÉSENTANT UNE ACTIVITÉ AGONISTE RENFORCÉE

German Title of Invention:

ANTIKÖRPER GEGEN CD40 MIT ERHÖHTER AGONISTISCHER AKTIVITÄT

SPC Number:

Dates

Filing date:

28/06/2016

Grant date:

07/08/2024

EP Publication Date:

09/01/2019

PCT Publication Date:

08/09/2017

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

07/08/2024

EP B1 Publication Date:

07/08/2024

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

28/06/2036

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

31/07/2024

 

 

Name:

The Rockefeller University

Address:

1230 York Avenue, New York, NY 10065, United States (US)

Inventor

1

Name:

DAHAN, Rony

Address:

United States (US)

2

Name:

RAVETCH, Jeffrey, V.

Address:

United States (US)

Priority

Priority Number:

201662304012 P

Priority Date:

04/03/2016

Priority Country:

United States (US)

Classification

IPC classification:

C07K 16/28; A61K 39/00;

Publication

European Patent Bulletin

Issue number:

202432

Publication date:

07/08/2024

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

31/12/2025

Annual Fee Number:

10

Annual Fee Amount:

131 Euro

Penalty Fee Amount:

20 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages